Exact Mass: 296.1583
Exact Mass Matches: 296.1583
Found 266 metabolites which its exact mass value is equals to given mass value 296.1583
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Methyl dihydrophaseate
Methyl dihydrophaseate is found in pulses. Methyl dihydrophaseate is isolated from French beans. Isolated from French beans. Methyl dihydrophaseate is found in pulses.
3,8-Dihydroxy-6-methoxy-7(11)-eremophilen-12,8-olide
3,8-Dihydroxy-6-methoxy-7(11)-eremophilen-12,8-olide is found in green vegetables. 3,8-Dihydroxy-6-methoxy-7(11)-eremophilen-12,8-olide is a constituent of Petasites japonicus (sweet coltsfoot). Constituent of Petasites japonicus (sweet coltsfoot). 3b,8a-Dihydroxy-6b-methoxy-7(11)-eremophilen-12,8-olide is found in green vegetables.
Panaxydol chlorohydrin
Panaxydol chlorohydrin is found in tea. Panaxydol chlorohydrin is isolated from Korean ginseng root. Isolated from Korean ginseng root. Panaxydol chlorohydrin is found in tea.
6-allyl-8b-Carboxy-ergoline
6-allyl-8b-Carboxy-ergoline is a metabolite of cabergoline. Cabergoline (brand names Dostinex and Cabaser), an ergot derivative, is a potent dopamine receptor agonist on D2 receptors. In vitro, rat studies show cabergoline has a direct inhibitory effect on pituitary lactotroph cells. It is frequently used as a first-line agent in the management of prolactinomas due to higher affinity for D2 receptor sites, less severe side effects, and more convenient dosing schedule than the older bromocriptine. (Wikipedia)
3beta-Hydroxy-5alpha-Hydroperoxycostic acid methyl ester
[4S-(4alpha,4aalpha,5alpha,8aalpha,9aalpha)]-4a,5,6,7,8,8a,9,9a-Octahydro-4,8a-dihydroxy-9a-methoxy-3,4a,5-trimethylnaphtho[2,3-b]furan-2(4H)-one
Propizepine
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
6S-acetyl-4R,5R-dimethyl-1R(10S)-epoxy-2R-hydroxy-7R-acetoxydecahydronaphthalene
1beta,10alpha-epoxy-4-methoxy-8-hydroxyglechomanolide
8-Methyl-3-methoxy-6,8,13,13a-tetrahydro-5H-isoquino[2,1-b][2,7]naphthyridin-2-ol
rugosic acid A methyl ester|rugosid acid A methyl ester
7alpha,10alpha-dihydroxy-1beta-methoxyeremophil-11(13)-en-12,8beta-olide
5-acetyloxy-3,9a-dihydroxy-9a-homomegastigma-6,7-dien-9-one
4beta,10beta-dihydroxy-1alpha-methoxy-5alpha,11alphaH-guaia-2-en-12,6alpha-olide
Me ester -(4alpha,6alpha,11xi)-4,6-Dihydroxy-9-oxo-7-eudesmen-12-oic acid
8beta,10beta-dihydroxy-6beta-methoxyeremophil-7(11)-en-12,8alpha-olide|8beta,10beta-dihydroxy-6beta-methoxyleremophilenolide|8??,10??-Dihydroxy-6??-methoxyeremophil-7(11)-en-12,8??-olide
1beta,10beta-epoxy-7beta-hydroxy-8alpha-methoxyeremophil-11alphaH-12,8beta-olide
(+)-kopsihainanine A|(1S,3R,4aR,11cS)-3,4,5,6,7,11c-hexahydro-3-hydroxy-1,4a-propano-4aH-pyrido[3,2-c]carbazol-2(1H)-one|kopsihainanine A
(1R*, 1aS*, 4R*, 7R*, 7aS*, 7b*, 5Z)-4,4a,7-trihydroxyaromadendr-5-en-8-oic acid methyl ester
10alpha,13-dihydroxy-1beta-methoxyeremophil-7(11)-en-12,8beta-olide
4,10-dihydroxy-8-methoxyguai-7(11)-en-8,12-olide|8-O-methylzedoarolide B
(4aR,5S,8R,8aS,9aS)-4a,5,6,7,8,8a,9,9a-octahydro-8,8a-dihydroxy-9a-methoxy-3,4a,5-trimethylnaphtho[2,3-b]furan-2(4H)-one|1beta,10beta-dihydroxy-8beta-methoxyeremophil-7(11)-en-12,8alpha-olide
(1R,4aS,5R,8aR)-1,2,3,4,4a,5,8,8a-octahydro-5-hydroxy-5-(hydroxymethyl)-1,4a,6-trimethyl-8-oxonaphthalene-1-carboxylic acid methyl ester|loxocalyxins B
12, 13-Dihydro, Ac-(3E, 6S, 7S, 9Z, 12Z)-7-Chloro-3, 9, 12-pentadecatrien-1-yn-6-ol
4beta,5beta-epoxy-3beta-hydroxy-10alpha-methoxy-11alphaH-guaia-1-en-12,6beta-olide
8-Acetoxymethyl-6-methyl-8,9-didehydro-ergolin|8-acetoxymethyl-6-methyl-8,9-didehydro-ergoline|elymoclavine acetate|Elymodavine-acetate|O-acetyl-elymoclavine|O-Acetylelymoclavin
(2S)-1-[2,6-dimethoxy-4-(prop-2-enyl)phenoxy]-3-methylbutane-2,3-diol|lenisin A
1beta,3beta,6alpha-trihydroxycostic acid methyl ester
methyl 1beta,2beta,6alpha-trihydroxy-5alpha,7alphaH-eudesma-4(15),11(13)-dien-12-oate
Oxymetazoline hydrochloride
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents
(E)-4-hydroxy-4-[4-hydroxy-2-[(E)-6-oxohept-1-enyl]cyclopentyl]but-2-enoic acid
C16H24O5_2-Naphthaleneacetic acid, 1,2,3,4,4a,5,8,8a-octahydro-1,8-dihydroxy-alpha,4a,8-trimethyl-5-oxo-, methyl ester
C16H24O5_4-Hydroxy-5-methoxy-4-[2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl]-1-oxaspiro[2.5]octan-6-one
C16H24O5_Cyclohexaneacetic acid, 4-ethenyl-2,6-dihydroxy-3-[1-(hydroxymethyl)ethenyl]-4-methyl-alpha-methylene-, methyl ester
methyl 2-[4-ethenyl-2,6-dihydroxy-3-(3-hydroxyprop-1-en-2-yl)-4-methylcyclohexyl]prop-2-enoate
Methyl dihydrophaseate
3,8-Dihydroxy-6-methoxy-7(11)-eremophilen-12,8-olide
Methyl 2-[2,6-dihydroxy-3-(3-hydroxy-1-propen-2-yl)-4-methyl-4-vinylcyclohexyl]acrylate
5-tert-Butyl 1-ethyl 3-aminopyrrolo[3,4-c]pyrazole-1,5(4H,6H)-dicarboxylate
3-aminomethyl-2-cbz-1,2,3,4-tetrahydro-isoquinoline
3,5-di-tert-butyl-4-hydroxybenzenepropanoyl chloride
Guanethidine sulfate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
(R)-BENZYL METHYL(1,2,3,4-TETRAHYDROQUINOLIN-3-YL)CARBAMATE
1-methyl-1-phenyl-N,N-bis(trimethylsilyl)-Silanediamine
Ethyl 4-[[(ethylphenylamino)methylene]amino]benzoate
7-tert-Butyl 3-ethyl 5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-3,7(8H)-dicarboxylate
Phosphonium,tributyl(carboxymethyl)-, chloride (1:1)
4-[3-(4-aminocyclohexa-1,3-dien-1-yl)oxyphenoxy]cyclohexa-1,3-dien-1-amine
4-[4-(cyclopentylamino)-2-methylpyrimidin-5-yl]benzamide
Ropinirole hydrochloride
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent Ropinirole (SKF 101468) hydrochloride is an orally active, potent D3/D2 receptor agonist with a Ki of 29 nM for D2 receptor. Ropinirole hydrochloride has pEC50s of 7.4, 8.4 and 6.8 for hD2, hD3 and hD4 receptors, respectively. Ropinirole hydrochloride has no affinity for the D1 receptors. Ropinirole hydrochloride has the potential for Parkinson's disease[1][2].
1-[1-(tert-butoxycarbonyl)piperidin-4-yl]-1H-1,2,3-triazole-4-carboxylic acid
l-Glutamic acid, N-coco acyl derivs., compds. with triethanolamine (1:1)
[1-[3-(4-Methylphenoxy)propyl]-2-benzimidazolyl]methanol
methyl 2-(1,8-dihydroxy-4a,8-dimethyl-5-oxo-2,3,4,8a-tetrahydro-1H-naphthalen-2-yl)propanoate
1-(2,3-dihydro-1H-inden-5-yl)-3-(2-ethoxyphenyl)urea
(Furan-2-yl)[4-(3-phenylallyl)piperazin-1-yl]methanone
N-(1-propyl-3-pyrazolo[3,4-b]quinolinyl)butanamide
N-cyclohexyl-2-(5-methyl-2-furanyl)-3-imidazo[1,2-a]pyrimidinamine
1-(2-Methoxyethyl)-2-[(4-methylphenoxy)methyl]benzimidazole
N-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)oxan-3-yl]-2-fluorobenzamide
N-[(2S,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)oxan-3-yl]-2-fluorobenzamide
N-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2R,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
(E)-4-hydroxy-4-[4-hydroxy-2-[(E)-6-oxohept-1-enyl]cyclopentyl]but-2-enoic acid
N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol(1+)
(5Z)-3a-Hydroxy-5-[(E)-2-methylbut-2-enylidene]-1-phenyl-3,6-dihydro-2H-pyrrolo[2,3-b]pyridin-4-one
(2-{[3-(3,4-Dihydroxy-5-methoxyphenyl)prop-2-enoyl]oxy}ethyl)trimethylazanium
(1S,7R,14S)-9-hydroxy-15,17-diazatetracyclo[12.2.2.13,7.18,12]icosa-3(20),4,8,10,12(19)-pentaen-6-one
2,6-Dimethyl-5-ethoxy-3-methoxy-(6R)-((2R)-2-methylbutyryloxy)-2,4-cyclohexadien-1-one
SN40
SN40 is a potent amino acid transport (AAT) inhibitor with Kis of 7.29 μM, 2.42 μM, 2.94 μM, 5.55 μM, 24.43 μM and 5.55 μM for rat ASCT2, human ASCT2, EAAT1, EAAT2, EAAC1 and EAAT5, respectively. SN40 can be used for researching anticancer[1].
(8r,9s,10r)-10-chloroheptadec-16-en-4,6-diyne-8,9-diol
3-{3-[(acetyloxy)methyl]-6-isopropylcyclohex-2-en-1-yl}-2-(hydroxymethyl)prop-2-enoic acid
(1r,6r,9s,10s)-6,10-dihydroxy-15-methyl-8,16-dioxatricyclo[7.7.1.0²,⁷]heptadec-2(7)-en-3-one
(1s,2r,5r,6s,9r,10s,12s,13s)-12-hydroxy-9-methoxy-5,9,13-trimethyl-3,14-dioxatetracyclo[8.4.0.0¹,¹³.0²,⁶]tetradecan-4-one
(1s,12s,13r,17r)-3,19-dimethyl-15-oxa-3,19-diazapentacyclo[10.6.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁷]nonadeca-2(10),4,6,8-tetraen-16-one
(3s,9r,10s)-10-chloroheptadec-1-en-4,6-diyne-3,9-diol
6-hydroxy-2-(1-hydroxy-6-oxoheptyl)-2,3,4,6,7,8-hexahydro-1-benzopyran-5-one
(2r,3r,5r,7s)-2-hydroxy-5-(2-hydroxypropan-2-yl)-11,11-dimethyl-4,10-dioxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-13-one
6-heptyl-4,5-dihydroxy-5-methyl-2-methylidene-4h,6h-furo[2,3-b]pyran-3-one
(1s,3s,6r,7s,8s,11s)-7-hydroxy-5-(hydroxymethyl)-11-isopropyl-3-methoxy-6-methyl-9-oxatricyclo[6.2.1.0²,⁶]undec-4-en-10-one
(4s,4as,5s,8as,9as)-8a,9a-dihydroxy-4-methoxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,9h-naphtho[2,3-b]furan-2-one
12-hydroxy-14-methoxy-1,9-dimethyl-4-methylidene-6,13-dioxatricyclo[8.4.0.0³,⁷]tetradecan-5-one
(2r,3r,4r,9r)-4-hydroxy-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraen-6-one
3-hydroxy-4-[(2r)-6-hydroxy-2-methoxy-6-methylheptan-2-yl]benzoic acid
(1s,5r,8r,9r)-8-hydroxy-4-(2-methoxypropan-2-yl)-10-oxatricyclo[7.2.1.0¹,⁵]dodec-3-ene-8-carboxylic acid
7-hydroxy-5-(2-hydroxypropan-2-yl)-11,11-dimethyl-4,10-dioxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-13-one
methyl 2-(8a-hydroperoxy-1-hydroxy-4a-methyl-8-methylidene-hexahydro-1h-naphthalen-2-yl)prop-2-enoate
(2s,6s)-6-hydroxy-2-[(1s)-1-hydroxy-6-oxoheptyl]-2,3,4,6,7,8-hexahydro-1-benzopyran-5-one
methyl (1r,2r,5r,7s,10s)-10-hydroxy-2-isopropyl-5-methyl-11,12-dioxatricyclo[5.3.2.0¹,⁵]dodec-8-ene-8-carboxylate
methyl 2-[(1r,2r,3r,4s,6s)-4-ethenyl-2,6-dihydroxy-3-(3-hydroxyprop-1-en-2-yl)-4-methylcyclohexyl]prop-2-enoate
(4r,5r,6r)-6-heptyl-4,5-dihydroxy-5-methyl-2-methylidene-4h,6h-furo[2,3-b]pyran-3-one
(1r,3s,6r,7s,9s,10r,13s)-7-hydroxy-3-methoxy-6,9,10-trimethyl-4,14-dioxatetracyclo[7.5.0.0¹,¹³.0³,⁷]tetradecan-5-one
7-o-methylpseudomajucin
{"Ingredient_id": "HBIN013419","Ingredient_name": "7-o-methylpseudomajucin","Alias": "NA","Ingredient_formula": "C16H24O5","Ingredient_Smile": "CC1C(CC23C1(CC(=O)O2)CC4(C(C3(CO4)C)C)OC)O","Ingredient_weight": "296.36 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14696","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11781435","DrugBank_id": "NA"}
8β,10β-dihydroxy-6β-methoxyeremophil-7(11)-en-12,8α-olide
{"Ingredient_id": "HBIN013648","Ingredient_name": "8\u03b2,10\u03b2-dihydroxy-6\u03b2-methoxyeremophil-7(11)-en-12,8\u03b1-olide","Alias": "NA","Ingredient_formula": "C16H24O5","Ingredient_Smile": "CC1CCCC2(C1(C(C3=C(C(=O)OC3(C2)O)C)OC)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5976","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}